Medications for Obstructive Sleep Apnea to Improve Cognition in Children With Down Syndrome
Conditions:   Obstructive Sleep Apnea;   Down Syndrome Intervention:   Drug: Atomoxetine and Oxybutynin (ato-oxy) Sponsors:   University of Arizona;   National Institutes of Health (NIH);   National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2023 Category: Research Source Type: clinical trials

Obstructive Sleep Apnea - Autonomic and Vascular Exploration
Condition:   Obstructive Sleep Apnea Intervention:   Other: CPAP withdrawal Sponsor:   Raphael Heinzer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 27, 2023 Category: Research Source Type: clinical trials